-
41
Pitfalls in Diagnosis: JMML versus KMT2A Rearranged Juvenile AML
Published 2024-01-01“…Lysine methyltransferase 2A (KMT2A) rearrangements are commonly found in juvenile acute myeloid leukaemia (AML). Although distinct diseases, there is a known clinical overlap between KMT2A-rearranged AML and juvenile myelomonocytic leukaemia (JMML). …”
Get full text
Article -
42
Analysis of Signals Leading to Differentiation of Immature HL-60 after Administration of IL-4
Published 1994-01-01“…Treatment of acute myeloid leukaemia (AML) cells with differentiation agents leads not only to the acquisition of normal phenotypes but also contributes to the understanding of special immuno-haematology issues. …”
Get full text
Article -
43
Acute Coronary Syndrome as an Unusual Initial Presentation of T-Prolymphocytic Leukemia: A Case Report and Review of the Literature
Published 2024-01-01“…T-prolymphocytic leukaemia (T-PLL) is the most common mature T-cell leukaemia in Central Europe and is often manifested by rapidly increasing lymphocytosis, marked bone marrow infiltration and splenomegaly. …”
Get full text
Article -
44
A Molecular, Genetic, and Diagnostic Spotlight on Fanconi Anemia
Published 2012-01-01Get full text
Article -
45
-
46
Leukemia Inhibitory Factor: Roles in Embryo Implantation and in Nonhormonal Contraception
Published 2014-01-01“…Leukaemia inhibitory factor (LIF) plays an indispensible role in embryo implantation. …”
Get full text
Article -
47
Haemorrhagic Colitis Caused by Dasatinib
Published 2012-01-01“…Here we present a case of a 59-year-old man with chronic myeloid leukaemia (CML) developing the rarest complication of haemorrhagic colitis with dasatinib therapy which resolved rapidly after treatment withdrawal.…”
Get full text
Article -
48
Mitoxantrone and acquired Long-QT Syndrome. Case presentation.
Published 2009-05-01“…We report a patient with diagnosis of leukaemia who was treated with mitoxantrone and presented syncope. …”
Get full text
Article -
49
Oral Squamous Cell Carcinoma Arising in a Patient after Hematopoietic Stem Cell Transplantation with Bisphosphonate-Related Osteonecrosis of the Jaws
Published 2015-01-01“…A 55-year-old man with a history of acute myeloid leukaemia treated with hematopoietic stem cell transplantation and with a 5-year history of bisphosphonate-related osteonecrosis of the jaws, following 12 cycles of intravenous zoledronic acid therapy, presented in December 2009 with a history of increasingly severe unilateral lower jaw pain. …”
Get full text
Article -
50
UPDATE ON CYTOMEGALOVIRUS INFECTION MANAGEMENT IN ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS
Published 2024-08-01Get full text
Article -
51
Evaluation of a Telemedicine System for the Transmission of Morpho/Immunological Data Aiming at the Inclusion of Patients in a Therapeutic Trial
Published 2009-01-01“…We present one of the first approaches of the use of telehaematology for the inclusion of patients in the GOELAMS chronic lymphocytic leukaemia 98 trial. The advantages were (1) the creation of a unique, protected, stable data bank that could be remotely consulted, (2) the use of digitized pictures which made expertise on identical documents possible, (3) the facility of computer exchanges between experts, in terms of reception as well as replying time delays. …”
Get full text
Article -
52
Heterogeneity in NK Cell Subpopulations May Be Involved in Kidney Cancer Metastasis
Published 2022-01-01“…Gene set enrichment analysis revealed that NK(EGR1) and NK(CAPG) were closely related to tumour metastasis, as shown by kidney cancer metastasis to Hodgkin lymphoma, T-cell leukaemia, and Ki-1+ anaplastic large cell lymphoma. …”
Get full text
Article -
53
Laboratory Diagnosis of Invasive Aspergillosis: From Diagnosis to Prediction of Outcome
Published 2013-01-01“…Invasive aspergillosis (IA), an infection caused by fungi in the genus Aspergillus, is seen in patients with immunological deficits, particularly acute leukaemia and stem cell transplantation, and has been associated with high rates of mortality in previous years. …”
Get full text
Article -
54
Mitohormesis : la clé de voûte de la résistance thérapeutique des cellules cancéreuses
Published 2024-08-01“…In this review, we are particularly interested in acute myeloid leukaemia, where mitochondrial metabolism plays a key role in response and resistance to treatment. …”
Get full text
Article -
55
Numb Chin Syndrome as First Symptom of Diffuse Large B-Cell Lymphoma
Published 2014-01-01“…Haematological malignancies like acute lymphocytic leukaemia, Hodgkin and non-Hodgkin lymphoma, and myeloma can cause this neuropathy. …”
Get full text
Article -
56
Priapism in a Child from Homocystinuria from Methylenetetrahydrofolate Reductase MTHFR (C677T) Mutation
Published 2023-01-01“…It can be caused by ischaemia in sickle cell anaemia, leukaemia, trauma, drugs, or idiopathy. Homocystinuria is a rare autosomal recessive disorder that can cause hyperhomocysteinemia and hypercoagulability. …”
Get full text
Article -
57
Ensemble Based Box-Cox Transformation via Meta Analysis
Published 2022-09-01“…The proposed approach is implemented on white blood count data of leukaemia patients which are not normally distributed. …”
Get full text
Article -
58
Performance Augmentation of Base Classifiers Using Adaptive Boosting Framework for Medical Datasets
Published 2023-01-01“…., global cancer map (GCM), lymphoma-I, lymphoma-II, leukaemia, and embryonal tumours. The evaluation focuses on the accuracy, precision, and efficiency of the base classifiers in the AdaBoost framework. …”
Get full text
Article -
59
Kolaviron and L-Ascorbic Acid Attenuate Chlorambucil-Induced Testicular Oxidative Stress in Rats
Published 2014-01-01“…Chlorambucil (4-[4-[bis(2-chloroethyl)amino]phenyl]butanoic acid) is an alkylating agent, indicated in chronic lymphocytic leukaemia. Kolaviron (KV), a biflavonoid complex from Garcinia kola, and L-ascorbic acid (AA) are known to protect against oxidative damage in vivo. …”
Get full text
Article -
60
Streptomyces-derived nano-doxorubicin: Clinical status and patents granted
Published 2024-01-01“…Doxorubicin (DOX) is a potent anti-cancer drug derived from Streptomyces, that is widely used for various cancers, including cancers of the ovary, urinary bladder, GI tract, breast, thyroid gland, lung, bone, kidney (nephroblastoma) and blood (leukaemia). This anthracycline antibiotic is limited by its adverse effect profile, with the main adverse effects being nausea, vomiting, alopecia, infertility, cardiotoxicity, myelosuppression and nephrotoxicity. …”
Get full text
Article